932 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 http://www.zacks.com/stock/news/730536/jazz-jazz-submits-nda-for-xyrem-follow-on-candidate-jzp-258?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-730536 Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Why Long-Term Investors Should Avoid TEVA Stock Like the Plague https://www.fool.com/investing/2020/01/22/why-long-term-investors-should-avoid-teva-stock-li.aspx?source=iedfolrf0000001 Jan 22, 2020 - Strapped with debt and battling legal controversies right and left, Teva’s best days could very well be behind it.
Why You Should Still Buy Teva https://seekingalpha.com/article/4318277-why-you-should-still-buy-teva?source=feed_tag_israel Jan 22, 2020 - Teva is set to hold the $10 support line.Company's restructuring and debt reduction on schedule.Future growth in place with two products leading it.
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495 Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe http://www.zacks.com/stock/news/727955/jazzs-jazz-new-sleep-drug-sunosi-gets-approval-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-727955 Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.
Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow https://seekingalpha.com/article/4316745-teva-pharmaceutical-teva-presents-38th-annual-j-p-morgan-healthcare-conference-slideshow?source=feed_tag_israel Jan 14, 2020 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event.
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) https://seekingalpha.com/article/4316595-teva-pharmaceutical-industries-limited-teva-ceo-kare-schultz-on-38th-annual-jp-morgan?source=feed_tag_israel Jan 13, 2020 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) 38th Annual JP Morgan Healthcare Conference January 13, 2020 01:30 PM ET Company Participants Kåre Schultz - President and Chief Executive Officer Co
Teva to pay $54M to settle suit over sham programs to boost drug sales https://seekingalpha.com/news/3529875-teva-to-pay-54m-to-settle-suit-over-sham-programs-to-boost-drug-sales?utm_source=feed_news_all&utm_medium=referral Jan 06, 2020 - The attorney representing two former sales reps at Teva Pharmaceutical Industries (TEVA -0.8%) announces that the company has agreed to pay $54M to settle allegations that it used sham paid speaker pr
My Top Portfolio Holdings for 2020 https://www.fool.com/investing/2019/12/30/my-top-portfolio-holdings-for-2020.aspx?source=iedfolrf0000001 Dec 30, 2019 - These four stocks will hopefully be bringing home the bacon in the new year.
Migraine sufferers have new oral medication with FDA approval of Allergan's Ubrelvy https://www.cnbc.com/2019/12/26/migraine-sufferers-have-new-tool-with-approval-of-allergans-ubrelvy.html Dec 26, 2019 - Ubrelvy is proven to ease migraine symptoms in two hours.

Pages: 123456...94

Page 1>